Domino Data Lab and Appsilon have joined forces to enhance the integration of open-source AI into regulated environments within the life sciences sector. This collaboration aims to streamline the transition from AI development using R and Python to compliant production workflows.
The partnership seeks to address a significant hurdle in the industry: many AI initiatives utilizing open-source tools struggle to reach production due to the absence of validated infrastructures that meet regulatory standards. By combining Domino's AI platform with Appsilon's extensive experience in open-source software, the collaboration offers a comprehensive solution for pharmaceutical and life sciences organizations.
Customers will benefit from Appsilon’s specialized knowledge in open-source R and Python development, as well as tools for deployment and migration from SAS to open-source. This integration allows for a seamless workflow from model creation to governed production, ensuring compliance throughout the process.
Additionally, the partnership has introduced Axon.R, a new extension for Domino that focuses on R package validation. This tool employs risk-based methodologies to ensure compliance-ready package validation within the AI development environment. As highlighted by executives from both companies, the collaboration not only enhances the capabilities of Domino’s platform but also provides a much-needed pathway for life sciences organizations to effectively deploy AI solutions while adhering to regulatory requirements.
This partnership underscores the growing need for validated infrastructures in the life sciences sector, enabling companies to leverage AI technologies while maintaining compliance. As the demand for efficient AI deployment continues to rise, collaborations like this may play a crucial role in bridging the gap between innovation and regulatory adherence.